Full-Time

Vice President

Head of Drug Safety

Posted on 4/2/2024

Revolution Medicines

Revolution Medicines

201-500 employees

Develops precision oncology therapies

Biotechnology

Compensation Overview

$265,000 - $350,000Annually

+ Equity

Senior, Expert

San Carlos, CA, USA

Required Skills
Communications
Marketing
Requirements
  • Advanced degree in pharmacy, medicine, life sciences, or a related field.
  • Extensive experience (minimum 8-10 years) in drug safety/pharmacovigilance within the pharmaceutical or biotechnology industry, with progressive leadership responsibilities.
  • In-depth knowledge of global pharmacovigilance regulations and guidelines (e.g., FDA, EMA, ICH).
  • Strong leadership and management skills, with a track record of building and developing high-performing teams.
  • Excellent communication, interpersonal, and influencing skills, with the ability to effectively collaborate with internal and external stakeholders.
  • Proven ability to think strategically, drive innovation, and implement process improvements in drug safety operations.
  • Experience interacting with regulatory agencies and participating in regulatory inspections and audits is highly desirable.
Responsibilities
  • Develop and implement the strategic vision for the Drug Safety department, aligning with the company's goals and objectives.
  • Provide leadership and guidance to a team of drug safety professionals, fostering a culture of excellence, collaboration, and continuous improvement.
  • Drive initiatives to optimize drug safety processes, systems, and workflows to enhance efficiency and effectiveness.
  • Oversee the evaluation of safety data from preclinical studies, clinical trials, post-marketing surveillance, and literature sources to assess and mitigate potential risks associated with our drug products.
  • Lead the preparation of safety reports, including Development Safety Update Reports (DSURs), Periodic Safety Update Reports (PSURs), and Risk Management Plans (RMPs), for submission to regulatory authorities.
  • Collaborate with cross-functional teams to develop risk minimization strategies and safety interventions as necessary.
  • Ensure compliance with global regulatory requirements and guidelines related to pharmacovigilance and drug safety.
  • Serve as the primary point of contact for regulatory agencies on drug safety matters, including participation in regulatory inspections and audits.
  • Keep abreast of emerging regulations and industry trends to proactively adapt drug safety processes and practices.
  • Lead the ongoing monitoring and analysis of safety data to detect potential signals of adverse events or emerging safety concerns.
  • Conduct thorough investigations of safety signals, including the review of individual case reports, aggregate data, and relevant scientific literature.
  • Collaborate with stakeholders to assess the clinical relevance and potential impact of identified signals and recommend appropriate actions.
  • Work closely with clinical development, medical affairs, regulatory affairs, and other relevant departments to integrate drug safety considerations into product development strategies and clinical trial designs.
  • Provide expert guidance and support to cross-functional teams on safety-related issues, including protocol development, risk assessment, and safety monitoring activities.

Revolution Medicines specializes in developing precision oncology therapies, particularly RAS(ON) inhibitors and RAS Companion inhibitors, with their lead product candidate, RMC-4630, currently in a Phase 1/2 clinical program targeting specific oncogenic mutations in various tumor types. The company's main focus is on developing these therapies to target specific oncogenic mutations in different tumor types, utilizing precision oncology technologies.

Company Stage

IPO

Total Funding

$1.3B

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

22%

1 year growth

50%

2 year growth

102%
INACTIVE